EGFR and breast carcinoma: On the other hand, knockdown of MGAT5 showed no effect on Epidermal Growth Factor (EGF) binding to Epidermal Growth Factor Receptor (EGFR), but resulted in reduced EGF-promoted activation of focal adhesion kinase and attenuation of the invasive phenotype in breast carcinoma cells [39].